why choose us

First received: June 30, 2023

Clinical Trial: Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Gout

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open Lable, Multi-center, Active Competitor Phase 2 Study for Evaluating Efficacy and Safety of Genakumab for Injection as First Line Therapy in Patients With Gout Flare

Brief Summary: To evaluate the safety and efficacy of Genakumab for Injection in patients with gout flare as a first line therapy

Read more